|
1
|
Tossetta G, Avellini C, Licini C,
Giannubilo SR, Castellucci M and Marzioni D: High temperature
requirement A1 and fibronectin: Two possible players in placental
tissue remodelling. Eur J Histochem. 60:27242016.
|
|
2
|
Fantone S, Giannubilo SR, Marzioni D and
Tossetta G: HTRA family proteins in pregnancy outcome. Tissue Cell.
72:1015492021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marzioni D, Todros T, Cardaropoli S, Rolfo
A, Lorenzi T, Ciarmela P, Romagnoli R, Paulesu L and Castellucci M:
Activating protein-1 family of transcription factors in the human
placenta complicated by preeclampsia with and without fetal growth
restriction. Placenta. 31:919–927. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Todros T, Marzioni D, Lorenzi T, Piccoli
E, Capparuccia L, Perugini V, Cardaropoli S, Romagnoli R, Gesuita
R, Rolfo A, et al: Evidence for a role of TGF-beta1 in the
expression and regulation of alpha-SMA in fetal growth restricted
placentae. Placenta. 28:1123–1132. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marzioni D, Quaranta A, Lorenzi T, Morroni
M, Crescimanno C, De Nictolis M, Toti P, Muzzonigro G, Baldi A, De
Luca A and Castellucci M: Expression pattern alterations of the
serine protease HtrA1 in normal human placental tissues and in
gestational trophoblastic diseases. Histol Histopathol.
24:1213–1222. 2009.PubMed/NCBI
|
|
6
|
Cecati M, Sartini D, Campagna R, Biagini
A, Ciavattini A, Emanuelli M and Giannubilo SR: Molecular analysis
of endometrial inflammation in preterm birth. Cell Mol Biol
(Noisy-le-grand). 63:51–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tossetta G, Fantone S, Gesuita R, Di Renzo
GC, Meyyazhagan A, Tersigni C, Scambia G, Di Simone N and Marzioni
D: HtrA1 in gestational diabetes mellitus: A possible biomarker?
Diagnostics (Basel). 12:27052022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Licini C, Tossetta G, Avellini C, Ciarmela
P, Lorenzi T, Toti P, Gesuita R, Voltolini C, Petraglia F,
Castellucci M and Marzioni D: Analysis of cell-cell junctions in
human amnion and chorionic plate affected by chorioamnionitis.
Histol Histopathol. 31:759–767. 2016.PubMed/NCBI
|
|
9
|
Yates EF and Mulkey SB: Viral infections
in pregnancy and impact on offspring neurodevelopment: Mechanisms
and lessons learned. Pediatr Res. 96:64–72. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fantone S, Tossetta G, Cianfruglia L,
Frontini A, Armeni T, Procopio AD, Pugnaloni A, Gualtieri AF and
Marzioni D: Mechanisms of action of mineral fibres in a placental
syncytiotrophoblast model: An in vitro toxicology study. Chem Biol
Interact. 390:1108952024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abrantes-Soares F, Lorigo M and Cairrao E:
Effects of BPA substitutes on the prenatal and cardiovascular
systems. Crit Rev Toxicol. 52:469–498. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khan B, Allah Yar R, Khakwani AK, Karim S
and Arslan Ali H: Preeclampsia incidence and its maternal and
neonatal outcomes with associated risk factors. Cureus.
14:e311432022.PubMed/NCBI
|
|
13
|
No authors listed: ACOG practice bulletin
No. 202: Gestational hypertension and preeclampsia. Obstet Gynecol.
133:12019.
|
|
14
|
Magee LA, Brown MA, Hall DR, Gupte S,
Hennessy A, Karumanchi SA, Kenny LC, McCarthy F, Myers J, Poon LC,
et al: The 2021 international society for the study of hypertension
in pregnancy classification, diagnosis & management
recommendations for international practice. Pregnancy Hypertens.
27:148–169. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang KJ, Seow KM and Chen KH:
Preeclampsia: Recent advances in predicting, preventing, and
managing the maternal and fetal life-threatening condition. Int J
Environ Res Public Health. 20:29942023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gesuita R, Licini C, Picchiassi E,
Tarquini F, Coata G, Fantone S, Tossetta G, Ciavattini A,
Castellucci M, Di Renzo GC, et al: Association between first
trimester plasma htra1 level and subsequent preeclampsia: A
possible early marker? Pregnancy Hypertens. 18:58–62. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Deshpande JS, Sundrani DP, Sahay AS, Gupte
SA and Joshi SR: Unravelling the potential of angiogenic factors
for the early prediction of preeclampsia. Hypertens Res.
44:756–769. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fantone S, Mazzucchelli R, Giannubilo SR,
Ciavattini A, Marzioni D and Tossetta G: AT-rich interactive domain
1A protein expression in normal and pathological pregnancies
complicated by preeclampsia. Histochem Cell Biol. 154:339–346.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aneman I, Pienaar D, Suvakov S, Simic TP,
Garovic VD and McClements L: Mechanisms of key innate immune cells
in early- and late-onset preeclampsia. Front Immunol. 11:18642020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marin R, Chiarello DI, Abad C, Rojas D,
Toledo F and Sobrevia L: Oxidative stress and mitochondrial
dysfunction in early-onset and late-onset preeclampsia. Biochim
Biophys Acta Mol Basis Dis. 1866:1659612020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Staff AC: The two-stage placental model of
preeclampsia: An update. J Reprod Immunol. 134-135:1–10. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Örgül G, Aydın Haklı D, Özten G, Fadiloğlu
E, Tanacan A and Beksaç MS: First trimester complete blood cell
indices in early and late onset preeclampsia. Turk J Obstet
Gynecol. 16:112–117. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marzioni D, Lorenzi T, Altobelli E,
Giannubilo SR, Paolinelli F, Tersigni C, Crescimanno C, Monsurrò V,
Tranquilli AL, Di Simone N and Castellucci M: Alterations of
maternal plasma HTRA1 level in preeclampsia complicated by IUGR.
Placenta. 33:1036–1038. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Inversetti A, Pivato CA, Cristodoro M,
Latini AC, Condorelli G, Di Simone N and Stefanini G: Update on
long-term cardiovascular risk after pre-eclampsia: A systematic
review and meta-analysis. Eur Heart J Qual Care Clin Outcomes.
10:4–13. 2024. View Article : Google Scholar
|
|
25
|
Saito S, Shiozaki A, Nakashima A, Sakai M
and Sasaki Y: The role of the immune system in preeclampsia. Mol
Aspects Med. 28:192–209. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hahn S, Gupta AK, Troeger C, Rusterholz C
and Holzgreve W: Disturbances in placental immunology: Ready for
therapeutic interventions? Springer Semin Immunopathol. 27:477–493.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boulanger H, Bounan S, Mahdhi A, Drouin D,
Ahriz-Saksi S, Guimiot F and Rouas-Freiss N: Immunologic aspects of
preeclampsia. AJOG Glob Rep. 4:1003212024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Conforti-Andreoni C, Spreafico R, Qian HL,
Riteau N, Ryffel B, Ricciardi-Castagnoli P and Mortellaro A: Uric
acid-driven Th17 differentiation requires inflammasome-derived IL-1
and IL-18. J Immunol. 187:5842–5850. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saito S, Shiozaki A, Sasaki Y, Nakashima
A, Shima T and Ito M: Regulatory T cells and regulatory natural
killer (NK) cells play important roles in feto-maternal tolerance.
Semin Immunopathol. 29:115–122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saito S, Nakashima A, Shima T and Ito M:
Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J
Reprod Immunol. 63:601–610. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Figueiredo AS and Schumacher A: The T
helper type 17/regulatory T cell paradigm in pregnancy. Immunology.
148:13–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ribeiro VR, Romao-Veiga M, Romagnoli GG,
Matias ML, Nunes PR, Borges VTM, Peracoli JC and Peracoli MTS:
Association between cytokine profile and transcription factors
produced by T-cell subsets in early- and late-onset pre-eclampsia.
Immunology. 152:163–173. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eghbal-Fard S, Yousefi M, Heydarlou H,
Ahmadi M, Taghavi S, Movasaghpour A, Jadidi-Niaragh F, Yousefi B,
Dolati S, Hojjat-Farsangi M, et al: The imbalance of Th17/Treg axis
involved in the pathogenesis of preeclampsia. J Cell Physiol.
234:5106–5116. 2019. View Article : Google Scholar
|
|
34
|
Saito S and Sakai M: Th1/Th2 balance in
preeclampsia. J Reprod Immunol. 59:161–173. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kluger MA, Luig M, Wegscheid C, Goerke B,
Paust HJ, Brix SR, Yan I, Mittrücker HW, Hagl B, Renner ED, et al:
Stat3 programs Th17-specific regulatory T cells to control GN. J Am
Soc Nephrol. 25:1291–1302. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee JH, Kim TH, Oh SJ, Yoo JY, Akira S, Ku
BJ, Lydon JP and Jeong JW: Signal transducer and activator of
transcription-3 (Stat3) plays a critical role in implantation via
progesterone receptor in uterus. FASEB J. 27:2553–2563. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Suman P, Malhotra SS and Gupta SK:
LIF-STAT signaling and trophoblast biology. JAKSTAT.
2:e251552013.
|
|
38
|
Fitzgerald JS, Busch S, Wengenmayer T,
Foerster K, de la Motte T, Poehlmann TG and Markert UR: Signal
transduction in trophoblast invasion. Chem Immunol Allergy.
88:181–199. 2005.PubMed/NCBI
|
|
39
|
DiFederico E, Genbacev O and Fisher SJ:
Preeclampsia is associated with widespread apoptosis of placental
cytotrophoblasts within the uterine wall. Am J Pathol. 155:293–301.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tossetta G, Fantone S, Giannubilo SR,
Ciavattini A, Senzacqua M, Frontini A and Marzioni D: HTRA1 in
placental cell models: A possible role in preeclampsia. Curr Issues
Mol Biol. 45:3815–3828. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
He G, Xu W, Chen Y, Liu X and Xi M:
Abnormal apoptosis of trophoblastic cells is related to the
up-regulation of CYP11A gene in placenta of preeclampsia patients.
PLoS One. 8:e596092013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kisseleva T, Bhattacharya S, Braunstein J
and Schindler CW: Signaling through the JAK/STAT pathway, recent
advances and future challenges. Gene. 285:1–24. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gupta S, Yan H, Wong LH, Ralph S,
Krolewski J and Schindler C: The SH2 domains of Stat1 and Stat2
mediate multiple interactions in the transduction of IFN-alpha
signals. EMBO J. 15:1075–1084. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
El-Tanani M, Al Khatib AO, Aladwan SM,
Abuelhana A, McCarron PA and Tambuwala MM: Importance of STAT3
signaling in cancer, metastasis and therapeutic interventions. Cell
Signal. 92:1102752022. View Article : Google Scholar
|
|
45
|
Blake S, Hughes TP, Mayrhofer G and Lyons
AB: The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits
function of normal human T-lymphocytes in vitro. Clin Immunol.
127:330–339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cheranov SY, Karpurapu M, Wang D, Zhang B,
Venema RC and Rao GN: An essential role for SRC-activated STAT-3 in
14,15-EET-induced VEGF expression and angiogenesis. Blood.
111:5581–5591. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Murray PJ: The JAK-STAT signaling pathway:
Input and output integration. J Immunol. 178:2623–2629. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cortés-Ballinas L, López-Pérez TV and
Rocha-Zavaleta L: STAT3 and the STAT3-regulated inhibitor of
apoptosis protein survivin as potential therapeutic targets in
colorectal cancer (Review). Biomed Rep. 21:1752024. View Article : Google Scholar
|
|
49
|
Teng Y, Ross JL and Cowell JK: The
involvement of JAK-STAT3 in cell motility, invasion, and
metastasis. JAKSTAT. 3:e280862014.PubMed/NCBI
|
|
50
|
Fang Y, Feng X, Xue N, Cao Y, Zhou P and
Wei Z: STAT3 signaling pathway is involved in the pathogenesis of
miscarriage. Placenta. 101:30–38. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fitzgerald JS, Poehlmann TG, Schleussner E
and Markert UR: Trophoblast invasion: The role of intracellular
cytokine signaling via signal transducer and activator of
transcription 3 (STAT3). Hum Reprod Update. 14:335–344. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Borg AJ, Yong HEJ, Lappas M, Degrelle SA,
Keogh RJ, Da Silva-Costa F, Fournier T, Abumaree M, Keelan JA,
Kalionis B and Murthi P: Decreased STAT3 in human idiopathic fetal
growth restriction contributes to trophoblast dysfunction.
Reproduction. 149:523–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Weber M, Kuhn C, Schulz S, Schiessl B,
Schleussner E, Jeschke U, Markert UR and Fitzgerald JS: Expression
of signal transducer and activator of transcription 3 (STAT3) and
its activated forms is negatively altered in trophoblast and
decidual stroma cells derived from preeclampsia placentae.
Histopathology. 60:657–662. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Travaglino A, Raffone A, Saccone G,
Migliorini S, Maruotti GM, Esposito G, Mollo A, Martinelli P, Zullo
F and D'Armiento M: Placental morphology, apoptosis, angiogenesis
and epithelial mechanisms in early-onset preeclampsia. Eur J Obstet
Gynecol Reprod Biol. 234:200–206. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang Z, Yang X, Zhang L, Duan Z, Jia L,
Wang P, Shi Y, Li Y and Gao J: Decreased expression and activation
of Stat3 in severe preeclampsia. J Mol Histol. 46:205–219. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yang HY: MiR-133b regulates oxidative
stress injury of trophoblasts in preeclampsia by mediating the
JAK2/STAT3 signaling pathway. J Mol Histol. 52:1177–1188. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhou W, Wang H, Yang J, Long W, Zhang B,
Liu J and Yu B: Down-regulated circPAPPA suppresses the
proliferation and invasion of trophoblast cells via the
miR-384/STAT3 pathway. Biosci Rep. 39:BSR201919652019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liu M, Liao L, Gao Y, Yin Y, Wei X, Xu Q,
Gao L and Zhou R: BCAM deficiency may contribute to preeclampsia by
suppressing the PIK3R6/p-STAT3 signaling. Hypertension.
79:2830–2842. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Xu X, Zhu M, Zu Y, Wang G, Li X and Yan J:
Nox2 inhibition reduces trophoblast ferroptosis in preeclampsia via
the STAT3/GPX4 pathway. Life Sci. 343:1225552024. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Qu HM, Qu LP, Li XY and Pan XZ:
Overexpressed HO-1 is associated with reduced STAT3 activation in
preeclampsia placenta and inhibits STAT3 phosphorylation in
placental JEG-3 cells under hypoxia. Arch Med Sci. 14:597–607.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang Z, Wang X, Wang J and Zhang L: The
decreased expression of Stat3 and p-Stat3 in preeclampsia-like rat
placenta. J Mol Histol. 49:175–183. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wang H, Liu ML, Chu C, Yu SJ, Li J, Shen
HC, Meng Q and Zhang T: Paeonol alleviates placental inflammation
and apoptosis in preeclampsia by inhibiting the JAK2/STAT3
signaling pathway. Kaohsiung J Med Sci. 38:1103–1112. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang GJ, Yang Z, Huai J and Xiang QQ:
Pravastatin alleviates oxidative stress and decreases placental
trophoblastic cell apoptosis through IL-6/STAT3 signaling pathway
in preeclampsia rats. Eur Rev Med Pharmacol Sci. 24:12955–12962.
2020.PubMed/NCBI
|
|
64
|
Abdelzaher WY, Mostafa-Hedeab G, Bahaa HA,
Mahran A, Atef Fawzy M, Abdel Hafez SMN, Welson NN and Rofaeil RR:
Leukotriene receptor antagonist, montelukast ameliorates
L-NAME-induced pre-eclampsia in rats through suppressing the
IL-6/Jak2/STAT3 signaling pathway. Pharmaceuticals (Basel).
15:9142022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
George EM and Arany I: Induction of heme
oxygenase-1 shifts the balance from proinjury to prosurvival in the
placentas of pregnant rats with reduced uterine perfusion pressure.
Am J Physiol Regul Integr Comp Physiol. 302:R620–R626. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Saad AF, Diken ZM, Kechichian TB, Clark
SM, Olson GL, Saade GR and Costantine MM: Pravastatin effects on
placental prosurvival molecular pathways in a mouse model of
preeclampsia. Reprod Sci. 23:1593–1599. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Lecarpentier E and Tsatsaris V: Angiogenic
balance (sFlt-1/PlGF) and preeclampsia. Ann Endocrinol (Paris).
77:97–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kar M: Role of biomarkers in early
detection of preeclampsia. J Clin Diagn Res. 8:BE01–BE04.
2014.PubMed/NCBI
|
|
69
|
Levine RJ, Maynard SE, Qian C, Lim KH,
England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein
FH, et al: Circulating angiogenic factors and the risk of
preeclampsia. N Engl J Med. 350:672–683. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
van Meeteren LA, Goumans MJ and ten Dijke
P: TGF-β receptor signaling pathways in angiogenesis; emerging
targets for anti-angiogenesis therapy. Curr Pharm Biotechnol.
12:2108–2120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Ives CW, Sinkey R, Rajapreyar I, Tita ATN
and Oparil S: Preeclampsia-pathophysiology and clinical
presentations: JACC state-of-the-art review. J Am Coll Cardiol.
76:1690–1702. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Rajakumar A, Michael HM, Rajakumar PA,
Shibata E, Hubel CA, Karumanchi SA, Thadhani R, Wolf M, Harger G
and Markovic N: Extra-placental expression of vascular endothelial
growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by
peripheral blood mononuclear cells (PBMCs) in normotensive and
preeclamptic pregnant women. Placenta. 26:563–573. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zolfaghari MA, Motavalli R,
Soltani-Zangbar MS, Parhizkar F, Danaii S, Aghebati-Maleki L, Noori
M, Dolati S, Ahmadi M, Samadi Kafil H, et al: A new approach to the
preeclampsia puzzle; MicroRNA-326 in CD4+ lymphocytes
might be as a potential suspect. J Reprod Immunol. 145:1033172021.
View Article : Google Scholar
|
|
74
|
Mathur AN, Chang HC, Zisoulis DG,
Stritesky GL, Yu Q, O'Malley JT, Kapur R, Levy DE, Kansas GS and
Kaplan MH: Stat3 and Stat4 direct development of IL-17-secreting Th
cells. J Immunol. 178:4901–4907. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Davis GK, Fehrenbach DJ and Madhur MS:
Interleukin 17A: Key player in the pathogenesis of hypertension and
a potential therapeutic target. Curr Hypertens Rep. 23:132021.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Bowman T, Garcia R, Turkson J and Jove R:
STATs in oncogenesis. Oncogene. 19:2474–2488. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bushway ME, Gerber SA, Fenton BM, Miller
RK, Lord EM and Murphy SP: Morphological and phenotypic analyses of
the human placenta using whole mount immunofluorescence. Biol
Reprod. 90:1102014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zozzaro-Smith PE, Bushway ME, Gerber SA,
Hebert D, Pressman EK, Lord EM, Miller RK and Murphy SP: Whole
mount immunofluorescence analysis of placentas from normotensive
versus preeclamptic pregnancies. Placenta. 36:1310–1317. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Lykke JA, Langhoff-Roos J, Sibai BM, Funai
EF, Triche EW and Paidas MJ: Hypertensive pregnancy disorders and
subsequent cardiovascular morbidity and type 2 diabetes mellitus in
the mother. Hypertension. 53:944–951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Männistö T, Mendola P, Vääräsmäki M,
Järvelin MR, Hartikainen AL, Pouta A and Suvanto E: Elevated blood
pressure in pregnancy and subsequent chronic disease risk.
Circulation. 127:681–690. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Rana S, Lemoine E, Granger JP and
Karumanchi SA: Preeclampsia: Pathophysiology, challenges, and
perspectives. Circ Res. 124:1094–1112. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Christensen M, Petersen JL, Sivanandam P,
Kronborg CS, Knudsen UB and Martensen PM: Reduction of
serum-induced endothelial STAT3(Y705) activation is associated with
preeclampsia. Pregnancy Hypertens. 25:103–109. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Harmon AC, Cornelius DC, Amaral LM,
Faulkner JL, Cunningham MW Jr, Wallace K and LaMarca B: The role of
inflammation in the pathology of preeclampsia. Clin Sci (Lond).
130:409–419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Tossetta G, Fantone S, Licini C, Marzioni
D and Mattioli-Belmonte M: The multifaced role of HtrA1 in the
development of joint and skeletal disorders. Bone. 157:1163502022.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Tossetta G, Fantone S, Busilacchi EM, Di
Simone N, Giannubilo SR, Scambia G, Giordano A and Marzioni D:
Modulation of matrix metalloproteases by ciliary neurotrophic
factor in human placental development. Cell Tissue Res.
390:113–129. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Tossetta G, Fantone S, Piani F,
Crescimanno C, Ciavattini A, Giannubilo SR and Marzioni D:
Modulation of NRF2/KEAP1 signaling in preeclampsia. Cells.
12:15452023. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Tossetta G, Fantone S, Marzioni D and
Mazzucchelli R: Role of natural and synthetic compounds in
modulating NRF2/KEAP1 signaling pathway in prostate cancer. Cancers
(Basel). 15:30372023. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Ray PP, Islam MA, Islam MS, Han A, Geng P,
Aziz MA and Mamun AA: A comprehensive evaluation of the therapeutic
potential of silibinin: A ray of hope in cancer treatment. Front
Pharmacol. 15:13497452024. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Xu LN, Xu RA, Zhang D, Su SS, Xu HY, Wu Q
and Li YP: The changes of expressive levels of IL-17A, STAT3, and
RORγt in different invasive pulmonary aspergillosis mice. Infect
Drug Resist. 11:1321–1328. 2018. View Article : Google Scholar :
|
|
90
|
Ribeiro VR, Romao-Veiga M, Nunes PR, de
Oliveira LRC, Romagnoli GG, Peracoli JC and Peracoli MTS: Silibinin
downregulates the expression of the Th1 and Th17 profiles by
modulation of STATs and transcription factors in pregnant women
with preeclampsia. Int Immunopharmacol. 109:1088072022. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zhang L, Li DC and Liu LF: Paeonol:
Pharmacological effects and mechanisms of action. Int
Immunopharmacol. 72:413–421. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Chen X, Zhang Z, Zhang X, Jia Z, Liu J,
Chen X, Xu A, Liang X and Li G: Paeonol attenuates heart failure
induced by transverse aortic constriction via ERK1/2 signalling.
Pharm Biol. 60:562–569. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Feldman D, Krishnan AV, Swami S,
Giovannucci E and Feldman BJ: The role of vitamin D in reducing
cancer risk and progression. Nat Rev Cancer. 14:342–357. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Zhang H, Shih DQ and Zhang X: Mechanisms
underlying effects of 1,25-Dihydroxyvitamin D3 on the Th17 cells.
Eur J Microbiol Immunol (Bp). 3:237–240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Sassi F, Tamone C and D'Amelio P: Vitamin
D: Nutrient, hormone, and immunomodulator. Nutrients. 10:16562018.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Xu L, Lee M, Jeyabalan A and Roberts JM:
The relationship of hypovitaminosis D and IL-6 in preeclampsia. Am
J Obstet Gynecol. 210:149.e1–e7. 2014. View Article : Google Scholar
|
|
97
|
Ribeiro VR, Romao-Veiga M, Nunes PR, de
Oliveira LRC, Romagnoli GG, Peracoli JC and Peracoli MTS:
Immunomodulatory effect of vitamin D on the STATs and transcription
factors of CD4+ T cell subsets in pregnant women with
preeclampsia. Clin Immunol. 234:1089172022. View Article : Google Scholar
|
|
98
|
Bhasin D, Cisek K, Pandharkar T, Regan N,
Li C, Pandit B, Lin J and Li PK: Design, synthesis, and studies of
small molecule STAT3 inhibitors. Bioorg Med Chem Lett. 18:391–395.
2008. View Article : Google Scholar
|
|
99
|
Huang W, Dong Z, Wang F, Peng H, Liu JY
and Zhang JT: A small molecule compound targeting STAT3 DNA-binding
domain inhibits cancer cell proliferation, migration, and invasion.
ACS Chem Biol. 9:1188–1196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Schust J, Sperl B, Hollis A, Mayer TU and
Berg T: Stattic: A small-molecule inhibitor of STAT3 activation and
dimerization. Chem Biol. 13:1235–1242. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Mendola P, Nobles C, Williams A, Sherman
S, Kanner J, Seeni I and Grantz K: Air pollution and preterm birth:
Do air pollution changes over time influence risk in consecutive
pregnancies among low-risk women? Int J Environ Res Public Health.
16:33652019. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Yang S, Tan Y, Mei H, Wang F, Li N, Zhao
J, Zhang Y, Qian Z, Chang JJ, Syberg KM, et al: Ambient air
pollution the risk of stillbirth: A prospective birth cohort study
in Wuhan, China. Int J Hyg Environ Health. 221:502–509. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Zhang H, Dong H, Ren M, Liang Q, Shen X,
Wang Q, Yu L, Lin H, Luo Q, Chen W, et al: Ambient air pollution
exposure and gestational diabetes mellitus in Guangzhou, China: A
prospective cohort study. Sci Total Environ. 699:1343902020.
View Article : Google Scholar
|
|
104
|
Wang Q, Zhang H, Liang Q, Knibbs LD, Ren
M, Li C, Bao J, Wang S, He Y, Zhu L, et al: Effects of prenatal
exposure to air pollution on preeclampsia in Shenzhen, China.
Environ Pollut. 237:18–27. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Hu L, Huang B, Bai S, Tan J, Liu Y and
Chen H, Liu Y, Zhu L, Zhang J and Chen H: SO2
derivatives induce dysfunction in human trophoblasts via inhibiting
ROS/IL-6/STAT3 pathway. Ecotoxicol Environ Saf. 210:1118722021.
View Article : Google Scholar
|
|
106
|
Sirtori CR: The pharmacology of statins.
Pharmacol Res. 88:3–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Marrs CC and Costantine MM: Should we add
pravastatin to aspirin for preeclampsia prevention in high-risk
women? Clin Obstet Gynecol. 60:161–168. 2017. View Article : Google Scholar :
|
|
108
|
Lu F, Bytautiene E, Tamayo E, Gamble P,
Anderson GD, Hankins GD, Longo M and Saade GR: Gender-specific
effect of overexpression of sFlt-1 in pregnant mice on fetal
programming of blood pressure in the offspring later in life. Am J
Obstet Gynecol. 197:418.e1–e5. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Maynard SE, Min JY, Merchan J, Lim KH, Li
J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, et
al: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may
contribute to endothelial dysfunction, hypertension, and
proteinuria in preeclampsia. J Clin Invest. 111:649–658. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Korthals-de Bos I, Van Tulder M, Boers M,
Verhoeven AC, Adèr HJ, Bibo J, Boonen A and Van Der Linden S:
Indirect and total costs of early rheumatoid arthritis: A
randomized comparison of combined step-down prednisolone,
methotrexate, and sulfasalazine with sulfasalazine alone. J
Rheumatol. 31:1709–1716. 2004.PubMed/NCBI
|
|
111
|
Cai C, Lu J, Lai L, Song D, Shen J, Tong
J, Zheng Q, Wu K, Qian J and Ran Z: Drug therapy and monitoring for
inflammatory bowel disease: A multinational questionnaire
investigation in Asia. Intest Res. 20:213–223. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Hastie R, Brownfoot FC, Pritchard N,
Hannan NJ, Cannon P, Nguyen V, Palmer K, Beard S, Tong S and
Kaitu'u-Lino TJ: EGFR (epidermal growth factor receptor) signaling
and the mitochondria regulate sFlt-1 (soluble FMS-like tyrosine
kinase-1) secretion. Hypertension. 73:659–670. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Hastie R, Brownfoot FC, Cannon P, Nguyen
V, Tuohey L, Hannan NJ, Tong S and Kaitu'u-Lino TJ: Sulfasalazine
decreases soluble fms-like tyrosine kinase-1 secretion potentially
via inhibition of upstream placental epidermal growth factor
receptor signaling. Placenta. 87:53–57. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Fantel AG, Nekahi N, Shepard TH, Cornel
LM, Unis AS and Lemire RJ: The teratogenicity of
N(omega)-nitro-L-ariginine methyl ester (L-NAME), a nitric oxide
synthase inhibitor, in rats. Reprod Toxicol. 11:709–717. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Hao H, Li F, Wang F, Ran J, Chen Y, Yang
L, Ma H, Wang J and Yang H: Protective effect of metformin on the
NG-nitro-l-arginine methyl ester (l-NAME)-induced rat models of
preeclampsia. Biochem Biophys Res Commun. 739:1509962024.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Liu S, Gao M, Zhang X, Wei J and Cui H:
FOXP2 overexpression upregulates LAMA4 expression and thereby
alleviates preeclampsia by regulating trophoblast behavior. Commun
Biol. 7:14272024. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Fitriana F, Soetrisno S, Sulistyowati S
and Indarto D: Evaluation of placental bed uterine in
L-NAME-induced early-onset preeclampsia (EO-PE) like the rat model.
Turk J Obstet Gynecol. 21:180–189. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Tomruk C, Şirin Tomruk C, Denizlioğlu B,
Olukman M, Ercan G, Duman S, Köse T, Çetin Uyanıkgil EÖ, Uyanıkgil
Y and Uysal A: Effects of apelin on neonatal brain neurogenesis in
L-NAME-induced maternal preeclampsia. Sci Rep. 14:193472024.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Palmsten K, Flores KF, Chambers CD, Weiss
LA, Sundaram R and Buck Louis GM: Most frequently reported
prescription medications and supplements in couples planning
pregnancy: The LIFE study. Reprod Sci. 25:94–101. 2018. View Article : Google Scholar :
|
|
120
|
Walia M, Lodha R and Kabra SK: Montelukast
in pediatric asthma management. Indian J Pediatr. 73:275–282. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Yerraguravagari B, Penchikala NP, Kolusu
AS, Ganesh GS, Konduri P, Nemmani KVS and Samudrala PK: Montelukast
ameliorates scopolamine-induced Alzheimer's disease: Role on
cholinergic neurotransmission, antioxidant defence system,
neuroinflammation and expression of BDNF. CNS Neurol Disord Drug
Targets. 23:1040–1055. 2024. View Article : Google Scholar
|
|
122
|
Li P, Ma X, Huang D and Gu X: Exploring
the roles of non-coding RNAs in liver regeneration. Noncoding RNA
Res. 9:945–953. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Hill M and Tran N: miRNA interplay:
Mechanisms and consequences in cancer. Dis Model Mech.
14:dmm0476622021. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Dong K, Hou Y, Zhang N, Duan B, Ma A and
Zhang Z: Down-regulated placental miR-21 contributes to
preeclampsia through targeting RASA1. Hypertens Pregnancy.
40:236–245. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
He H, Zhang H, Li Z, Wang R, Li N and Zhu
L: miRNA-214: Expression, therapeutic and diagnostic potential in
cancer. Tumori. 101:375–383. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Li D, Xia L, Chen M, Lin C, Wu H, Zhang Y,
Pan S and Li X: miR-133b, a particular member of myomiRs, coming
into playing its unique pathological role in human cancer.
Oncotarget. 8:50193–50208. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Wang X, Li B, Wang J, Lei J, Liu C, Ma Y
and Zhao H: Evidence that miR-133a causes recurrent spontaneous
abortion by reducing HLA-G expression. Reprod Biomed Online.
25:415–424. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Licini C, Avellini C, Picchiassi E, Mensà
E, Fantone S, Ramini D, Tersigni C, Tossetta G, Castellucci C,
Tarquini F, et al: Pre-eclampsia predictive ability of maternal
miR-125b: A clinical and experimental study. Transl Res. 228:13–27.
2021. View Article : Google Scholar
|
|
129
|
Tang J, Wang D, Lu J and Zhou X: MiR-125b
participates in the occurrence of preeclampsia by regulating the
migration and invasion of extravillous trophoblastic cells through
STAT3 signaling pathway. J Recept Signal Transduct Res. 41:202–208.
2021. View Article : Google Scholar
|
|
130
|
Song X, Luo X, Gao Q, Wang Y, Gao Q and
Long W: Dysregulation of LncRNAs in placenta and pathogenesis of
preeclampsia. Curr Drug Targets. 18:1165–1170. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zhang TN, Wang W, Huang XM and Gao SY:
Non-coding RNAs and extracellular vehicles: Their role in the
pathogenesis of gestational diabetes mellitus. Front Endocrinol
(Lausanne). 12:6642872021. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S,
Jiang Z, Xu J, Liu Q and Cao X: The STAT3-binding long noncoding
RNA lnc-DC controls human dendritic cell differentiation. Science.
344:310–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Faas MM and De Vos P: Innate immune cells
in the placental bed in healthy pregnancy and preeclampsia.
Placenta. 69:125–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Zhang W, Zhou Y and Ding Y: Lnc-DC
mediates the over-maturation of decidual dendritic cells and
induces the increase in Th1 cells in preeclampsia. Am J Reprod
Immunol. 77:e126472017. View Article : Google Scholar
|
|
135
|
Zhang W, Yang M, Yu L, Hu Y, Deng Y, Liu
Y, Xiao S and Ding Y: Long non-coding RNA lnc-DC in dendritic cells
regulates trophoblast invasion via p-STAT3-mediated TIMP/MMP
expression. Am J Reprod Immunol. 83:e132392020. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Gao Q, Wang T, Pan L, Qian C, Wang J, Xin
Q, Liu Y, Zhang Z, Xu Y, He X and Cao Y: Circular RNAs: Novel
potential regulators in embryogenesis, female infertility, and
pregnancy-related diseases. J Cell Physiol. 236:7223–7241. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Zhou L, Duan Y, Fu K, Zhang M, Li K and
Yin R: The role of B7-H4 in ovarian cancer immunotherapy: Current
status, challenges, and perspectives. Front Immunol.
15:14260502024. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Duan L, Reisch B, Iannaccone A, Hadrovic
E, Wu Y, Vogtmann R, Winterhager E, Kimmig R, Köninger A, Mach P
and Gellhaus A: Abnormal expression of the costimulatory molecule
B7-H4 in placental chorionic villous and decidual basalis tissues
of patients with preeclampsia and HELLP syndrome. Am J Reprod
Immunol. 86:e134302021. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Mach P, Nolte-Boenigk L, Droste L, Fox L,
Frank M, Schmidt B, Herse F, Verlohren S, Wicherek L, Iannaccone A,
et al: Soluble B7-H4 blood serum levels are elevated in women at
high risk for preeclampsia in the first trimester, as well as in
patients with confirmed preeclampsia. Am J Reprod Immunol.
80:e129882018. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Ma Y, Duan L, Reisch B, Kimmig R,
Iannaccone A and Gellhaus A: Impact of the immunomodulatory factor
soluble B7-H4 in the progress of preeclampsia by inhibiting
essential functions of extravillous trophoblast cells. Cells.
13:13722024. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Li H, Zhou L and Dai J: Retinoic acid
receptor-related orphan receptor RORα regulates differentiation and
survival of keratinocytes during hypoxia. J Cell Physiol.
233:641–650. 2018. View Article : Google Scholar
|
|
142
|
Chauvet C, Bois-Joyeux B and Danan JL:
Retinoic acid receptor-related orphan receptor (ROR) alpha4 is the
predominant isoform of the nuclear receptor RORalpha in the liver
and is up-regulated by hypoxia in HepG2 human hepatoma cells.
Biochem J. 364:449–456. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Yu Y and Zhu T: RAR-related orphan
receptor: An accelerated preeclampsia progression by activating the
JAK/STAT3 pathway. Yonsei Med J. 63:554–563. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Kikkawa Y, Ogawa T, Sudo R, Yamada Y,
Katagiri F, Hozumi K, Nomizu M and Miner JH: The lutheran/basal
cell adhesion molecule promotes tumor cell migration by modulating
integrin-mediated cell attachment to laminin-511 protein. J Biol
Chem. 288:30990–31001. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Yang WH, Huang Z, Wu J, Ding CC, Murphy SK
and Chi JT: A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell
death and chemoresistance in epithelial ovarian cancer. Mol Cancer
Res. 18:79–90. 2020. View Article : Google Scholar :
|
|
146
|
Cao Y, Luo F, Peng J, Fang Z, Liu Q and
Zhou S: KMT2B-dependent RFK transcription activates the TNF-α/NOX2
pathway and enhances ferroptosis caused by myocardial
ischemia-reperfusion. J Mol Cell Cardiol. 173:75–91. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Zhao Y, Wang C, Yang T, Wang H, Zhao S,
Sun N, Chen Y, Zhang H and Fan H: Chlorogenic Acid alleviates
chronic stress-induced duodenal ferroptosis via the inhibition of
the IL-6/JAK2/STAT3 signaling pathway in rats. J Agric Food Chem.
70:4353–4361. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Zhang W, Gong M, Zhang W, Mo J, Zhang S,
Zhu Z, Wang X, Zhang B, Qian W, Wu Z, et al: Thiostrepton induces
ferroptosis in pancreatic cancer cells through STAT3/GPX4
signaling. Cell Death Dis. 13:6302022. View Article : Google Scholar
|
|
150
|
Jiang Z, Li S, Han MJ, Hu GM and Cheng P:
High expression of NSUN5 promotes cell proliferation via cell cycle
regulation in colorectal cancer. Am J Transl Res. 12:3858–3870.
2020.PubMed/NCBI
|
|
151
|
Zhang H, Li H, Yao J, Zhao M and Zhang C:
The mutation of NSUN5 R295C promotes preeclampsia by impairing
decidualization through downregulating IL-11Rα. iScience.
27:1088992024. View Article : Google Scholar
|
|
152
|
Graham AM and Presnell JS: Hypoxia
inducible factor (HIF) transcription factor family expansion,
diversification, divergence and selection in eukaryotes. PLoS One.
12:e01795452017. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Qu H, Yu Q, Jia B, Zhou W, Zhang Y and Mu
L: HIF-3α affects preeclampsia development by regulating EVT growth
via activation of the Flt-1/JAK/STAT signaling pathway in hypoxia.
Mol Med Rep. 23:682021. View Article : Google Scholar
|
|
154
|
Gerke V and Moss SE: Annexins: From
structure to function. Physiol Rev. 82:331–371. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Alli-Shaik A, Wee S, Lim LHK and Gunaratne
J: Phosphoproteomics reveals network rewiring to a pro-adhesion
state in annexin-1-deficient mammary epithelial cells. Breast
Cancer Res. 19:1322017. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Lee SH, Lee PH, Kim BG, Seo HJ, Baek AR,
Park JS, Lee JH, Park SW, Kim DJ, Park CS and Jang AS: Annexin A1
in plasma from patients with bronchial asthma: Its association with
lung function. BMC Pulm Med. 18:12018. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Perucci LO, Carneiro FS, Ferreira CN,
Sugimoto MA, Soriani FM, Martins GG, Lima KM, Guimarães FL,
Teixeira AL, Dusse LM, et al: Annexin A1 is increased in the plasma
of preeclamptic women. PLoS One. 10:e01384752015. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Perucci LO, Vieira ÉLM, Teixeira AL, Gomes
KB, Dusse LM and Sousa LP: Decreased plasma concentrations of
brain-derived neurotrophic factor in preeclampsia. Clin Chim Acta.
464:142–147. 2017. View Article : Google Scholar
|
|
159
|
Feng J, Wang X, Li H, Wang L and Tang Z:
Silencing of Annexin A1 suppressed the apoptosis and inflammatory
response of preeclampsia rat trophoblasts. Int J Mol Med.
42:3125–3134. 2018.PubMed/NCBI
|
|
160
|
Xue Y, Luo M, Hu X, Li X, Shen J, Zhu W,
Huang L, Hu Y, Guo Y, Liu L, et al: Macrophages regulate vascular
smooth muscle cell function during atherosclerosis progression
through IL-1β/STAT3 signaling. Commun Biol. 5:13162022. View Article : Google Scholar
|
|
161
|
Cruceriu D, Baldasici O, Balacescu O and
Berindan-Neagoe I: The dual role of tumor necrosis factor-alpha
(TNF-α) in breast cancer: Molecular insights and therapeutic
approaches. Cell Oncol (Dordr). 43:1–18. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Sreenivasan L, Wang H, Yap SQ, Leclair P,
Tam A and Lim CJ: Autocrine IL-6/STAT3 signaling aids development
of acquired drug resistance in group 3 medulloblastoma. Cell Death
Dis. 11:10352020. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Ma JH, Qin L and Li X: Role of STAT3
signaling pathway in breast cancer. Cell Commun Signal. 18:332020.
View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Mo HQ, Tian FJ, Li X, Zhang J, Ma XL, Zeng
WH, Lin Y and Zhang Y: ANXA7 regulates trophoblast proliferation
and apoptosis in preeclampsia. Am J Reprod Immunol. 82:e131832019.
View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Xu C, Li X, Guo P and Wang J:
Hypoxia-induced activation of JAK/STAT3 signaling pathway promotes
trophoblast cell viability and angiogenesis in preeclampsia. Med
Sci Monit. 23:4909–4917. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Yoshida H and Hunter CA: The immunobiology
of interleukin-27. Annu Rev Immunol. 33:417–443. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Yin N, Zhang H, Luo X, Ding Y, Xiao X, Liu
X, Shan N, Zhang X, Deng Q, Zhuang B and Qi H: IL-27 activates
human trophoblasts to express IP-10 and IL-6: implications in the
immunopathophysiology of preeclampsia. Mediators Inflamm.
2014:9268752014. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Ge H, Yin N, Han TL, Huang D, Chen X, Xu
P, He C, Tong C and Qi H: Interleukin-27 inhibits trophoblast cell
invasion and migration by affecting the epithelial-mesenchymal
transition in preeclampsia. Reprod Sci. 26:928–938. 2019.
View Article : Google Scholar
|
|
169
|
Cao J, Inoue K, Li X, Drummond G and
Abraham NG: Physiological significance of heme oxygenase in
hypertension. Int J Biochem Cell Biol. 41:1025–1033. 2009.
View Article : Google Scholar :
|
|
170
|
Tsuchihashi S, Zhai Y, Bo Q, Busuttil RW
and Kupiec-Weglinski JW: Heme oxygenase-1 mediated cytoprotection
against liver ischemia and reperfusion injury: Inhibition of type-1
interferon signaling. Transplantation. 83:1628–1634. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Csongradi E, Docarmo JM, Dubinion JH, Vera
T and Stec DE: Chronic HO-1 induction with cobalt protoporphyrin
(CoPP) treatment increases oxygen consumption, activity, heat
production and lowers body weight in obese melanocortin-4
receptor-deficient mice. Int J Obes (Lond). 36:244–253. 2012.
View Article : Google Scholar
|
|
172
|
Downey JM, Davis AM and Cohen MV:
Signaling pathways in ischemic preconditioning. Heart Fail Rev.
12:181–188. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Xuan YT, Guo Y, Han H, Zhu Y and Bolli R:
An essential role of the JAK-STAT pathway in ischemic
preconditioning. Proc Natl Acad Sci USA. 98:9050–9055. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Hilfiker-Kleiner D, Hilfiker A and Drexler
H: Many good reasons to have STAT3 in the heart. Pharmacol Ther.
107:131–137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Andrés O, Kellermann T, López-Giráldez F,
Rozas J, Domingo-Roura X and Bosch M: RPS4Y gene family evolution
in primates. BMC Evol Biol. 8:1422008. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Chen Y, Chen Y, Tang C, Zhao Q, Xu T, Kang
Q, Jiang B and Zhang L: RPS4Y1 promotes high glucose-induced
endothelial cell apoptosis and inflammation by activation of the
p38 MAPK signaling. Diabetes Metab Syndr Obes. 14:4523–4534. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Chen X, Tong C, Li H, Peng W, Li R, Luo X,
Ge H, Ran Y, Li Q, Liu Y, et al: Dysregulated expression of RPS4Y1
(ribosomal protein S4, Y-linked 1) impairs STAT3 (signal transducer
and activator of transcription 3) signaling to suppress trophoblast
cell migration and invasion in preeclampsia. Hypertension.
71:481–490. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Boonstra J, Rijken P, Humbel B, Cremers F,
Verkleij A and van Bergen en Henegouwen P: The epidermal growth
factor. Cell Biol Int. 19:413–430. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Armant DR, Fritz R, Kilburn BA, Kim YM,
Nien JK, Maihle NJ, Romero R and Leach RE: Reduced expression of
the epidermal growth factor signaling system in preeclampsia.
Placenta. 36:270–278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Malik A, Pal R and Gupta SK:
Interdependence of JAK-STAT and MAPK signaling pathways during
EGF-mediated HTR-8/SVneo cell invasion. PLoS One. 12:e01782692017.
View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Chen LJ, Han ZQ, Zhou H, Zou L and Zou P:
Inhibition of HLA-G expression via RNAi abolishes resistance of
extravillous trophoblast cell line TEV-1 to NK lysis. Placenta.
31:519–527. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Cecati M, Giannubilo SR, Emanuelli M,
Tranquilli AL and Saccucci F: HLA-G and pregnancy adverse outcomes.
Med Hypotheses. 76:782–784. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Liu X, Gu W and Li X: HLA-G regulates the
invasive properties of JEG-3 choriocarcinoma cells by controlling
STAT3 activation. Placenta. 34:1044–1052. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Huppertz B: The anatomy of the normal
placenta. J Clin Pathol. 61:1296–1302. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Kannaiyan J, Muthukutty P, Iqbal MDT and
Paulraj B: Villous chorion: A potential source for pluripotent-like
stromal cells. J Nat Sci Biol Med. 8:221–228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Chu Y, Zhu C, Yue C, Peng W, Chen W, He G,
Liu C, Lv Y, Gao G, Yao K, et al: Chorionic villus-derived
mesenchymal stem cell-mediated autophagy promotes the proliferation
and invasiveness of trophoblasts under hypoxia by activating the
JAK2/STAT3 signaling pathway. Cell Biosci. 11:1822021. View Article : Google Scholar
|
|
187
|
Valesini G and Alessandri C: New facet of
antiphospholipid antibodies. Ann N Y Acad Sci. 1051:487–497. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Di Simone N, Caliandro D, Castellani R,
Ferrazzani S and Caruso A: Interleukin-3 and human trophoblast: In
vitro explanations for the effect of interleukin in patients with
antiphospholipid antibody syndrome. Fertil Steril. 73:1194–1200.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Branch DW and Khamashta MA:
Antiphospholipid syndrome: Obstetric diagnosis, management, and
controversies. Obstet Gynecol. 101:1333–1344. 2003.PubMed/NCBI
|
|
190
|
Mulla MJ, Brosens JJ, Chamley LW, Giles I,
Pericleous C, Rahman A, Joyce SK, Panda B, Paidas MJ and Abrahams
VM: Antiphospholipid antibodies induce a pro-inflammatory response
in first trimester trophoblast via the TLR4/MyD88 pathway. Am J
Reprod Immunol. 62:96–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Mulla MJ, Myrtolli K, Brosens JJ, Chamley
LW, Kwak-Kim JY, Paidas MJ and Abrahams VM: Antiphospholipid
antibodies limit trophoblast migration by reducing IL-6 production
and STAT3 activity. Am J Reprod Immunol. 63:339–348. 2010.
View Article : Google Scholar : PubMed/NCBI
|
